SCHEMBL7474156

SCHEMBL7474156

NC(=O)c1cccc(N=O)c1I

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 11/20 0.46
▸ HPGD P15428 10/20 0.46
▸ KDM4E B2RXH2 9/20 0.46
▸ LMNA P02545 4/20 0.46
▸ MAPT P10636 3/20 0.46
▸ RAB9A P51151 3/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ AKR1C3 P42330 2/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ AKR1C2 P52895 1/20 0.43
▸ AKR1C1 Q04828 1/20 0.43
▸ GAA P10253 2/20 0.41
▸ USP2 O75604 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ HSD17B10 Q99714 3/20 0.41
▸ TSHR P16473 1/20 0.41
▸ PBRM1 Q86U86 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27486058 0.81 KDM4E (0.52) ALDH1A1HPGDKDM4EMAPTRAB9A
SCHEMBL840117 0.79 ALDH1A1 (0.61) ALDH1A1HPGDKDM4ELMNAMAPT
SCHEMBL16511523 0.76 ALDH1A1 (0.49) ALDH1A1HPGDKDM4ELMNAMAPT
SCHEMBL652047 0.75 ALDH1A1 (0.46) ALDH1A1HPGDKDM4EMAPTGAA
SCHEMBL31493861 0.74 KDM4E (0.61) ALDH1A1HPGDKDM4ELMNAMAPT
SCHEMBL7466281 0.74 MMP2 (0.45) ALDH1A1HPGDKDM4EMAPTRAB9A
SCHEMBL12635358 0.74 KDM4E (0.61) ALDH1A1HPGDKDM4ELMNAMAPT
SCHEMBL7474161 0.73 ALDH1A1 (0.41) ALDH1A1HPGDKDM4ELMNAMAPT
SCHEMBL21296300 0.72 METAP2 (0.50) ALDH1A1HPGDKDM4EMAPTGAA
SCHEMBL4523553 0.72 MYC (0.48) ALDH1A1HPGDKDM4ELMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5877185-A THERAPY FOR CANCER OR RETROVIRUS OCTAMER, INC. (US) 1999-03-02 — — US disclosed
WO-1996022791-A9 NOVEL SYNERGISTIC COMPOSITIONS USEFUL AS ANTI-TUMOR OR ANTI-RETROVIRAL AGENTS — 1996-10-03 — — WO disclosed
WO-1996022791-A1 NOVEL SYNERGISTIC COMPOSITIONS USEFUL AS ANTI-TUMOR OR ANTI-RETROVIRAL AGENTS OCTAMER, INC. (US) 1996-08-01 — — WO disclosed
Send feedback